Valbiotis SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 1.51 million compared to EUR 0.748 million a year ago. Net loss was EUR 5.1 million compared to EUR 3.47 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.11 EUR | +4.31% | +4.71% | -17.80% |
Apr. 26 | Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 03 | Valbiotis: launch of Valbiotis PRO Cholesterol in May | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.80% | 66.59M | |
-3.25% | 102B | |
+1.71% | 96.29B | |
+2.13% | 22.18B | |
-15.72% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.23% | 16.36B | |
+5.25% | 13.97B | |
+33.14% | 12.17B |
- Stock Market
- Equities
- ALVAL Stock
- News VALBIOTIS
- Valbiotis SA Reports Earnings Results for the Half Year Ended June 30, 2022